Part 2 Summit Recap

Texas A&M Health held a highly successful in-person Summit in October 2022, with support from Genentech and Health Tech Austin.

HealthEquityInnovation.org provides a high-level summary of this Summit.

For the March 1st Virtual Summit, we continued this discussion and shared a community of practice in how data technologies can enhance health equity. We reviewed highlights from our in-person Summit and others sponsored by Genentech.

We reviewed national policy efforts and strategic initiatives to make precision medicine more equitable. We emphasised how pharma/tech companies address health equity issues and how their work can help reduce health disparities and improve public health. We welcome others to share what they are doing in this space and how we can redefine personalized medicine to be an equity facilitator rather than an equity barrier.

Our Agenda

Health Equity Innovation Part 2

How Do We Maximize Health Equity In Precision Health?

Presented by

March 1, 2023 | Virtual Event 9:00 am CT

Opening Remarks
Marcia Ory, PhD
Regents & Distinguished Professor
TAMU Health

The All of Us Research Program: Innovating for Health Equity
Martin Mendoza, PhD
Director of Health Equity
All of Us Research Program
National Institutes of Health

Genentech’s Approach to Supporting Health Equity
Veronica Sandoval, PhD, JD
Principal, Patient Inclusion & Health Equity
Genentech

Industry Opportunities to Improve the Patient Journey and Patient-Centric Data Governance in a Data Driven World

Moderator
Rick Silva, PhD
Executive Director
Center for Genomics & Precision Medicine
TAMU Health

Featured Speaker
Wendy Charles, PhD
Chief Scientific Officer
Burst IQ

Featured Speaker
Osama Alsaleh
Health Integration Partner
Oracle Health

Featured Speaker
Diana Attia
Executive Director
Regulatory Affairs International
Merck & Co.

Closing Remarks
Dr. Kenneth Ramos, MD PhD
Assistant Vice Chancellor for Health Affairs
TAMU Health

10:30 am CT